McMillan Shakespeare's novated inquiries continue to decline, while salary packaging is unchanged amid potential for an increase from the government health workforce.
Morgan Stanley assesses over-the-life revenue provide some stability. Target is $14. In-Line sector view. Equal-weight.
Sector: Commercial & Professional Services.
Target price is $14.00.Current Price is $7.38. Difference: $6.62 - (brackets indicate current price is over target). If MMS meets the Morgan Stanley target it will return approximately 47% (excluding dividends, fees and charges - negative figures indicate an expected loss).
© 2020 Acquisdata Pty Ltd., source FN Arena